Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03829618 · ClinicalTrials.gov registry record · Phase 3

Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound

A Phase 3 study, sponsored by Milton S. Hershey Medical Center.

Terminated
Registry status
Phase 3
Development phase
29
Enrollment target

NCT03829618 is a Phase 3 study that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 29 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03829618, a Phase 3 study, was terminated before completion, sponsored by Milton S. Hershey Medical Center.

TERMINATED
Registry status
Phase 3
Development phase
29 participants
Enrollment target

Study Summary

The purpose of this study is to assess if there is decrease in cough during flexible bronchoscopy and endobronchial ultrasound when different modes of lidocaine administration are used. The modes of administration being evaluated are topical, nebulized and atomized.

Interventions

  • DRUG Topical lidocaine
  • DRUG Nebuliser solution
  • DRUG Nebuliser Suspension

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2019-04-01
Est. Completion 2020-08-31
Phase Phase 3

Sponsor

Milton S. Hershey Medical Center

396 total trials

What the Registry Record Tells You About NCT03829618

The ClinicalTrials.gov registry entry for NCT03829618 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Topical lidocaine is the first listed.

NCT03829618 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03829618 about?

NCT03829618 is a clinical study titled "Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound". The purpose of this study is to assess if there is decrease in cough during flexible bronchoscopy and endobronchial ultrasound when different modes of lidocaine administration are used. The modes of administration being evaluated are topical, nebulized and atomized.

What is the current status of trial NCT03829618?

This trial is currently terminated. It is a Phase 3 study. The enrollment target is 29 participants. The study started on 2019-04-01. Estimated completion is 2020-08-31.

What interventions are being tested in trial NCT03829618?

The interventions under investigation include: Topical lidocaine (DRUG), Nebuliser solution (DRUG), Nebuliser Suspension (DRUG).

Who is sponsoring clinical trial NCT03829618?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.